Merit Medical Systems (MMSI) Stock Price, News & Analysis

Company Overview

Merit Medical Systems, Inc. is a medical device company that develops, manufactures and markets disposable products used in interventional, diagnostic and therapeutic procedures. Its portfolio is designed primarily for use by physicians in hospitals, outpatient facilities and other healthcare settings.

The company’s products support a range of specialties, including cardiovascular intervention, peripheral intervention, oncology, spine and pain management, general surgery, and critical care. Offerings include access and drainage devices, angiography and intervention products, biopsy and localization systems, embolization products, inflation devices, specialty needles, and other procedural tools.

Founded in 1987 and headquartered in South Jordan, Utah, Merit Medical serves healthcare providers through operations and distribution networks in the United States and international markets. The company was founded by Fred P. Lampropoulos, who has long been associated with its leadership.

Key Stats

• Today's Range: $86.77 to $87.85
• 50-Day Range: $73.11 to $91.98
• 52-Week Range: $59.74 to $94.75
• Volume: 43,770 shs
• Average Volume: 803,127 shs
• Market Capitalization: $5.25 billion
• P/E Ratio: 36.32
• Dividend Yield: N/A
• Price Target: $100.00
• Consensus Rating: Moderate Buy

Merit Medical Systems Stock Analysis - MarketRank™

Merit Medical Systems scored higher than 67% of companies evaluated by MarketBeat, and ranked 277th out of 908 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.6 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Merit Medical Systems has received a consensus rating of Moderate Buy. The company's average rating score is 2.83, and is based on 1 strong buy rating, 8 buy ratings, 3 hold ratings, and no sell ratings.

Upside Potential

Merit Medical Systems has a consensus price target of $100.00, representing about 14.5% upside from its current price of $87.30.

Amount of Analyst Coverage

Merit Medical Systems has been the subject of 10 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 8.59%

Earnings Growth

Earnings for Merit Medical Systems are expected to grow by 8.59% in the coming year, from $3.84 to $4.17 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Merit Medical Systems is 36.07, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.93.

Price to Earnings Ratio vs. Sector

The P/E ratio of Merit Medical Systems is 36.07, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.39.

Price to Earnings Growth Ratio

Merit Medical Systems has a PEG Ratio of 2.18. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Merit Medical Systems has a P/B Ratio of 3.27. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

6.64% of the float of Merit Medical Systems has been sold short.

Short Interest Ratio / Days to Cover

Merit Medical Systems has a short interest ratio ("days to cover") of 6.

Change versus previous month

Short interest in Merit Medical Systems has recently increased by 8.78%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Merit Medical Systems does not currently pay a dividend.

Dividend Growth

Merit Medical Systems does not have a long track record of dividend growth.

News and Social Media

• Score: 2.9 / 5
• News Sentiment: 1.60

News Sentiment

Merit Medical Systems has a news sentiment score of 1.60. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.73 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for Merit Medical Systems this week, compared to 5 articles on an average week.

Search Interest

Only 1 people have searched for MMSI on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.

Company Ownership

• Score: 0.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Merit Medical Systems insiders have not sold or bought any company stock.

Percentage Held by Insiders

0.70% of the stock of Merit Medical Systems is held by insiders.

Percentage Held by Institutions

99.66% of the stock of Merit Medical Systems is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 7/30/2026
• Today: 9/25/2026
• Next Earnings (Estimated): 10/29/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Supplies
• Current Symbol: NASDAQ:MMSI
• CIK: 856982
• Web: www.merit.com
• Phone: (801) 253-1600
• Fax: 801-253-1652
• Employees: 7,500
• Year Founded: 1987

Price Target and Rating

• Average Price Target for Merit Medical Systems: $100.00
• High Price Target: $114.00
• Low Price Target: $83.00
• Potential Upside/Downside: +14.1%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.83
• Research Coverage: 12 Analysts

Profitability

• EPS (Trailing Twelve Months): $2.42
• Trailing P/E Ratio: 36.22
• Forward P/E Ratio: 22.82
• P/E Growth: 2.18
• Net Income: $128.49 million
• Net Margins: 9.22%
• Pretax Margin: 12.32%
• Return on Equity: 13.75%
• Return on Assets: 8.10%

Debt

• Debt-to-Equity Ratio: 0.44
• Current Ratio: 4.20
• Quick Ratio: 2.79

Sales & Book Value

• Annual Sales: $1.52 billion
• Price / Sales: 3.45
• Cash Flow: $5.91 per share
• Price / Cash Flow: 14.84
• Book Value: $26.72 per share
• Price / Book: 3.28

Miscellaneous

• Outstanding Shares: 59,710,000
• Free Float: 59,292,000
• Market Cap: $5.23 billion
• Optionable: Optionable
• Beta: 0.49